M. Arriola

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris et al. · Nephrology Dialysis Transplantation · 2024 · 77 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

Francisco López‐Medrano, Mario Fernández‐Ruiz, J. T. Silva et al. · American Journal of Transplantation · 2016 · 73 citations · Full text

Medicine, Infectious Diseases, Microbiology +17

Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

Francisco López‐Medrano, J.T. Silva, Mario Fernández‐Ruiz et al. · American Journal of Transplantation · 2016 · 45 citations · Full text

Medicine, Infectious Diseases, Surgery +13

Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

Francisco López‐Medrano, Mario Fernández‐Ruiz, J.T. Silva et al. · Clinical Microbiology and Infection · 2017 · 35 citations · Full text

Medicine, Infectious Diseases, Nephrology +17